Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3 -ITD + normal karyotype AML patients

Blood (2016) 127 (3): 360–362.

https://doi.org/10.1182/blood-2015-08-662130

Published: 2016

Includes: Supplemental data

Journal Articles

Impact of Drug Transporters ABCB1 and ABCG2 and Regulators of Xenobiotic Transport and Metabolism Pxr and CAR Gene Polymorphisms on Clinical Efficacy of Imatinib in Chronic Myeloid Leukemia (CML)

Anna Stepien, MSc, Alessandro Martino, PhD, Federico Canzian, PhD, Daniele Campa, PhD, Angelika Stein, Joanna Gora-Tybor, MD PhD, Tomasz Sacha, MD PhD, Dorota Link-Lenczowska, PhD, Izabela Florek, PhD, Witold Prejzner, MD PhD, Zofia Specht-Szwoch, Malgorzata Calbecka, MD PhD, Marcin Rymko, MD PhD, Marek Dudzinski, MD PhD, Pawel Gaj, PhD, Tadeusz Robak, MD, Krzysztof Warzocha, MD PhD, Krzysztof Jamroziak, MD PhD

Blood (2014) 124 (21): 5222.

https://doi.org/10.1182/blood.V124.21.5222.5222

Published: 2014

Journal Articles

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Blood (2014) 124 (21): 3628.

https://doi.org/10.1182/blood.V124.21.3628.3628

Published: 2014

Journal Articles

Real-Life Comparison Of Severe Vascular Events and Other Non-Hematological Complications In CML Patients Treated With Second Line Nilotinib Or Dasatinib

Joanna Gora-Tybor, MD, PhD, Ewa Medras, MD, PhD, Malgorzata Calbecka, MD, PhD, Agnieszka Kolkowska, MD, Edyta Ponikowska-Szyba, MD, Tadeusz Robak, MD, PhD, Krzysztof Jamroziak, MD, PhD

Blood (2013) 122 (21): 1491.

https://doi.org/10.1182/blood.V122.21.1491.1491

Published: 2013

Journal Articles

Cladribine Alone and in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): Long-Term Follow-up of the the Polish Adult Leukemia Group (PALG CLL2) Study,

Blood (2011) 118 (21): 3915.

https://doi.org/10.1182/blood.V118.21.3915.3915

Published: 2011

Journal Articles

Long-Term Remission Maintenance on Weekly Imatinib Dosage In Patients with FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukaemia

Grzegorz Helbig, Marek Hus, Andrzej Moskwa, Krystyna Zawilska, MD, PhD, Lucyna Molendowicz-Portala, Alina Świderska, Alina Urbanowicz, Ewa ˙Zuk, Małgorzata Raźny, Marek Rodzaj, Ilona Seferyńska, Małgorzata Całbecka, Ryszard Wichary, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2010) 116 (21): 4097.

https://doi.org/10.1182/blood.V116.21.4097.4097

Published: 2010

Journal Articles

Treatment of Elderly Patients with Acute Myeloid Leukemia Adjusted to Age, Performance Status, Organ Function and the Presence of Co-Morbidities. Final Results of the Polish Adult Leukemia Group (PALG) 1/2005 Study.

Blood (2010) 116 (21): 1067.

https://doi.org/10.1182/blood.V116.21.1067.1067

Published: 2010

Journal Articles

Significance of Minimal Residual Disease in Patients with Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Iwona Solarska, PhD, Barbara Nasilowska-Adamska, MD, PhD, Maria Bieniaszewska, MD, PhD, Jan Maciej Zaucha, MD, PhD, Piotr Rzepecki, MD, PhD, Waldemar Sawicki, MD, Malgorzata Calbecka, MD, Ewa Lech-Maranda, MD, PhD, Bozena Marianska, MD, PhD, Krzysztof Warzocha, MD, PhD

Blood (2009) 114 (22): 3269.

https://doi.org/10.1182/blood.V114.22.3269.3269

Published: 2009

Journal Articles

Imatinib at Weekly Dosage May Induce and Maintain Haematologic and Molecular Remission in Chronic Eosinophilic Leukemia Harbouring FIP1L1-PDGFRA Fusion Gene- An Extended Follow-up Study.

Grzegorz Helbig, Malgorzata Calbecka, Justyna Gajkowska, Andrzej Moskwa, Alina Urbanowicz, Alina Swiderska, Jacek Najda, Slawomira Krzemien

Blood (2008) 112 (11): 1755.

https://doi.org/10.1182/blood.V112.11.1755.1755

Published: 2008

Journal Articles

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Cladribine

Blood (2008) 112 (11): 4179.

https://doi.org/10.1182/blood.V112.11.4179.4179

Published: 2008

Journal Articles

Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3).

Blood (2008) 112 (11): 2103.

https://doi.org/10.1182/blood.V112.11.2103.2103

Published: 2008

Journal Articles

Prognostic Value of BCR-ABL Transcript Amount for Early Relapse Detection in Chronic Myeloid Leukemia Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation.

Iwona Solarska, Miroslaw Majewski, MD, Barbara Nasilowska-Adamska, MD, Jan M. Zaucha, MD, PhD, Piotr Rzepecki, MD, Malgorzata Calbecka, MD, Kazimierz Sulek, MD, PhD, Andrzej Hellmann, MD, PhD, Bozena Marianska, MD, PhD, Krzysztof Warzocha, MD, PhD

Blood (2007) 110 (11): 5032.

https://doi.org/10.1182/blood.V110.11.5032.5032

Published: 2007

Journal Articles

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Blood (2007) 109 (9): 3672–3675.

https://doi.org/10.1182/blood-2006-08-042929

Published: 2007

Journal Articles

Randomized Comparison of Cladribine Plus Cyclophsophamide with Fludarabine Plus Cyclophosphamide in Progressive Chronic Lymphocytic Leukemia: An Updated Report of Prospective PALG-CLL3 Study.

Blood (2006) 108 (11): 2826.

https://doi.org/10.1182/blood.V108.11.2826.2826

Published: 2006

Journal Articles

Cladribine in Weekly Versus Daily Schedule for Untreated Active Hairy Cell Leukemia: Final Report of Polish Adult Leukemia Group (PALG) Prospective, Randomized, Multicenter Trial.

Blood (2006) 108 (11): 2485.

https://doi.org/10.1182/blood.V108.11.2485.2485

Published: 2006

Journal Articles

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2)

Blood (2006) 108 (2): 473–479.

https://doi.org/10.1182/blood-2005-12-4828

Published: 2006

Journal Articles

Randomized Comparison of Cladribine with Cyclophosphamide and Fludarabine with Cyclophosphamide in Previously Untreated Progressive and Symptomatic Chronic Lymphocytic Leukemia: The Interim Analysis of PALG CLL3 Trial.

Blood (2005) 106 (11): 2121.

https://doi.org/10.1182/blood.V106.11.2121.2121

Published: 2005

Journal Articles

Cladribine Alone or in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone as First Line Treatment in Chronic Lymphocytic Leukemia: An Early Report of Prospective Randomized Study.

Tadeusz Robak, MD, PhD, Jerzy Z. Blonski, Joanna Gora-Tybor, Marek Kasznicki, Jadwiga Dwilewicz-Trojaczek, Agnieszka Tomaszewska, Lech Konopka, Bernadeta Ceglarek, Janusz Kloczko, Jaroslaw Sokolowski, Anna Dmoszynska, Malgorzata Kowal, Krystyna Zawilska, Beata Stella-Holowiecka, Kazimierz Sulek, Kazimierz Kuliczkowski, Krzysztof Warzocha, Malgorzata Calbecka, Aleksander Skotnicki

Blood (2004) 104 (11): 337.

https://doi.org/10.1182/blood.V104.11.337.337

Published: 2004

Journal Articles

Randomized Comparison of Weekly Administration and Daily Courses of Cladribine in Patients with Hairy Cell Leukemia - Updated Results.

Tadeusz Robak, Marek Kasznicki, Joanna Gora-Tybor, Jadwiga Dwilewicz-Trojaczek, Anna Dmoszynska, Maria Wojtaszko, Barbara Zdziarska, Malgorzata Calbecka, Andrzej Hellmann, Beata Stella-Holowiecka, Kazimierz Sulek, Aleksander Skotnicki, Krystyna Zawilska, Janusz Kloczko, Krzysztof Warzocha, Lech Konopka

Blood (2004) 104 (11): 3478.

https://doi.org/10.1182/blood.V104.11.3478.3478

Published: 2004

NARROW

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3 -ITD + normal karyotype AML patients

Impact of Drug Transporters ABCB1 and ABCG2 and Regulators of Xenobiotic Transport and Metabolism Pxr and CAR Gene Polymorphisms on Clinical Efficacy of Imatinib in Chronic Myeloid Leukemia (CML)

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Real-Life Comparison Of Severe Vascular Events and Other Non-Hematological Complications In CML Patients Treated With Second Line Nilotinib Or Dasatinib

Cladribine Alone and in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): Long-Term Follow-up of the the Polish Adult Leukemia Group (PALG CLL2) Study,

Long-Term Remission Maintenance on Weekly Imatinib Dosage In Patients with FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukaemia

Treatment of Elderly Patients with Acute Myeloid Leukemia Adjusted to Age, Performance Status, Organ Function and the Presence of Co-Morbidities. Final Results of the Polish Adult Leukemia Group (PALG) 1/2005 Study.

Significance of Minimal Residual Disease in Patients with Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Imatinib at Weekly Dosage May Induce and Maintain Haematologic and Molecular Remission in Chronic Eosinophilic Leukemia Harbouring FIP1L1-PDGFRA Fusion Gene- An Extended Follow-up Study.

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Cladribine

Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3).

Prognostic Value of BCR-ABL Transcript Amount for Early Relapse Detection in Chronic Myeloid Leukemia Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation.

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Randomized Comparison of Cladribine Plus Cyclophsophamide with Fludarabine Plus Cyclophosphamide in Progressive Chronic Lymphocytic Leukemia: An Updated Report of Prospective PALG-CLL3 Study.

Cladribine in Weekly Versus Daily Schedule for Untreated Active Hairy Cell Leukemia: Final Report of Polish Adult Leukemia Group (PALG) Prospective, Randomized, Multicenter Trial.

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2)

Randomized Comparison of Cladribine with Cyclophosphamide and Fludarabine with Cyclophosphamide in Previously Untreated Progressive and Symptomatic Chronic Lymphocytic Leukemia: The Interim Analysis of PALG CLL3 Trial.

Cladribine Alone or in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone as First Line Treatment in Chronic Lymphocytic Leukemia: An Early Report of Prospective Randomized Study.

Randomized Comparison of Weekly Administration and Daily Courses of Cladribine in Patients with Hairy Cell Leukemia - Updated Results.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only